Common Contracts

4 similar Securities Purchase Agreement contracts by Altimmune, Inc., Cingulate Inc., Enveric Biosciences, Inc., Park Ha Biological Technology Co., Ltd.

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • January 28th, 2026 • Enveric Biosciences, Inc. • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of January 27, 2026, between Enveric Biosciences, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • January 28th, 2026 • Altimmune, Inc. • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of January 27, 2026, between Altimmune, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • January 28th, 2026 • Park Ha Biological Technology Co., Ltd. • Soap, detergents, cleang preparations, perfumes, cosmetics • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of January 26, 2026, between Park Ha Biological Technology Co., Ltd., a Cayman Islands business company (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • January 28th, 2026 • Cingulate Inc. • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of January 27, 2026, between Cingulate Inc., a Delaware corporation (the “Company”), and Castlehouse VCC – Harvest Win, a sub-fund of Castlehouse VCC, registered in Republic of Singapore (the “Singapore Entity” and a “Purchaser”), which is managed by Falcon Creek Capital Advisor LLC, and the other Purchasers listed on Schedule I.